Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Kazia TherapeuticsRezoluteImmunoprecise AntibodiesBiotronActinogen Medical
SymbolASX:KZANASDAQ:RZLTCVE:IPAASX:BITASX:ACW
Price Information
Current PriceA$0.59$0.09C$0.63A$0.12A$0.03
52 Week RangeN/ABuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$0.47N/AN/AN/A
% Upside from Price TargetN/A405.43% upsideN/AN/AN/A
Trade Information
Market Cap$36.68 million$27.57 millionC$44.20 million$80.72 million$29.10 million
BetaN/AN/AN/AN/AN/A
Average VolumeN/A49,69454,287N/AN/A
Sales & Book Value
Annual Revenue$1.00 millionN/AC$11.22 million$1.07 million$5.73 million
Price / Sales36.65N/A3.8278.515.08
CashflowA$0.09 per shareN/AC$0.04 per shareA$0.01 per shareA$0.01 per share
Price / Cash6.48N/A15.4511.003.75
Book ValueA$0.19 per shareN/AC$0.22 per shareA$0.01 per shareA$0.01 per share
Price / Book3.16N/A2.9313.332.36
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSA($0.16)N/AC($0.12)A$0.00A($0.01)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E Ratio∞∞∞∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A30.40%N/A3.56%
Current Ratio2.44%N/A1.12%14.02%11.42%
Quick Ratio2.38%N/A0.75%13.93%11.42%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/A20N/A3N/A
Shares Outstanding62.17 million293.32 million67.99 million701.93 million1.12 billion
Next Earnings DateN/AN/A3/25/2020 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel